Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT02625857 · COMPLETED
Trial details
- NCT number
- NCT02625857
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-10
- Primary completion
- 2018-07-03
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.